The “Containment” is the set of physical structures and activities that can isolate a product from the other elements.
The global situation of the leading pharmaceutical and chemical industries indicates that the number of active toxic products, “Potent drugs”, currently in production is around 95% of the total.
The main reason to use the containment technologies is the reduce of the risk posed to operators and the environment.
Another critical and constantly evolving aspect in the pharmaceutical sector is the need to protect the product from contamination due to the presence of personnel or the environment. In fact, that which matters most in pharmaceutical aseptic processes is the maximum reduction of the risk of product contamination, guided by the basic requirement of guaranteeing patient safety. Such contamination is basically due to particles, micro-organisms and endotoxins. The two main defences against these threats are processes with terminal sterilisation and aseptic processes.